Breast cancer detection
-
.DeepHealth Launches Next‑Gen Imaging Informatics and Clinical AI at RSNA 2025, Setting a New Standard for AI‑Driven Care
.DeepHealth (Nasdaq: RDNT) announced an expanded, cloud‑native portfolio at RSNA 2025, integrating Diagnostic, TechLive, Operations, and disease‑specific Clinical AI suites (Breast, Thyroid, Neuro, Chest, Prostate) on DeepHealth OS. Highlights include 400+ scanners linked to TechLive with a 42 % drop in MR closures, support for >10 million mammograms annually, a 21 % rise in breast‑cancer detection (579 k women), Thyroid Suite deployment at 200+ sites, and usage by over 2,000 customers and 5,000 radiologists. Chest and Prostate suites await U.S. 510(k) clearance.
